ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGFX Argentex Group Plc

56.00
-0.10 (-0.18%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Argentex Investors - AGFX

Argentex Investors - AGFX

Share Name Share Symbol Market Stock Type
Argentex Group Plc AGFX London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.10 -0.18% 56.00 16:35:03
Open Price Low Price High Price Close Price Previous Close
56.60 54.00 56.60 56.00 56.10
more quote information »
Industry Sector
NONEQUITY INVESTMENT INSTRUMENTS

Top Investor Posts

Top Posts
Posted at 01/2/2024 10:25 by mr roper
Stakebuilding. Staveley is a very active investor. Only have to look at his involvement in the turnaround at Pressure Tech. Suspect he'll be taking a closer interest here shortly
Posted at 11/11/2023 08:14 by jimtech
I was invested heavily in Argentex but I sold down earlier this year after reading the Google reviews at hxxps://maps.app.goo.gl/9g7PZBkAzPzpmQiq8

Here are some examples:

“Won't stop cold calling on the private number, lying to the reception to get through to the right person. No respectable company acts like this.”

"Constantly cold calling and rude to my staff when they wont give them my direct line. Won't be using them."

"Cold calling me daily. Not a way to get business in 2023."

"CONSTANTLY SPAM COLD CALLING ME. I AM REGISTERED ON TPS AND NOT INTERESTED. VERY RUDE SALES PEOPLE AND THE REASON I LEFT IS BECAUSE OF HOW EXPENSIVE U BECAME AFTER A COUPLE MONTHS."

"phone calls to private numbers without consent."

"Hassling, unsolicited contact, don't take no for an answer, avoid"

Clearly Argentex have a lot of work to do in their approach to winning business – from management to sales people - and it’s going to take a while to get back to growth.

And given their lack of transparency regarding their business activities AND TWO CEOs AND A CFO LEAVING IMMEDIATELY WITHOUT EXPLANATION (!!!!), I just don’t trust them to do what’s best for their shareholders.

Management - what is left of them - run this business like a private company leaving investors in the dark.

Arrogance and entitlement abounds.

Pleased to be out of it. It'll take a lot to convince me to buy in again.
Posted at 10/11/2023 10:10 by yump
Red Ninja

If the current board get rid of the ultimate decision makers who have led investors up the garden path, how can the current board lack credibility ?
Posted at 10/11/2023 09:31 by red ninja
This current board appear to have won the battle against the CEO/CFO presumably on the basis that trading performance was lagging, but investors were left in the dark.

Doesn't that indicate a lack of credibility ?
Posted at 09/11/2023 17:58 by earwacks
I think John Doe put it as succinctly as need be. Until we are enlightened. But don’t expect the board to volunteer anything. Jani lost about 40 percent on his extraordinary fire sale of 12 million shares on contracting Covid. Didn’t know healthcare was that expensive. Don’t they have Bupa? That’s the question on investors lips. Not again surely. Happy footnote just seen image of Jani (retired at 41) speeding around on a boat off some exotic coastline. Lovely to see recuperated so well
Posted at 29/10/2023 18:18 by maddox
Hi Smithie6,

The Top 20 clients - changes, that is - it's not as concentrated as that might suggest because it's not the same clients making up the top 20. Whether you think 40% of turnover in a period coming from just twenty clients is concentrated or diverse in any case - it's growing.

Also, the customer base is primarily business customers - not traders. Their requirements for fx may be occasional dependent upon their business needs. So, they are not catering to currency traders.

IMHO the immediate primary concern is the potential share overhang - Harry Adam's departure appears not to have been amicable. Hopefully the Broker can persuade him towards an organised sale or to hold-on until conditions are more conducive to achieving a higher price - if indeed he wishes to exit. It would clearly be useful to have some clarity on this in the market.

Underlying his departure appears to be a disagreement on strategy - so some clarity on what the new strategy is will certainly help investor sentiment.
Posted at 29/10/2023 17:36 by red ninja
Smithie629 Oct '23 - 14:57 - 1265 of 1266

So....as a tip from Inv store's champion

At 70-80p this tip has been a bad/losing tip ??

-----

I see no mention in the write up from them about the risk that comes from ~40% of turnover coming from the top 20 clients.

>>>

It may have been for some as it has been above that level.

In the full article they do mention the reliance on a few key clients.

It's fair to say they get some right and get some wrong like most investors.

Time will tell if the current entry point is a good opportunity or not.
Posted at 29/10/2023 17:28 by dr biotech
Customers didn't necessarily leave, they just didn't trade. Some may have left, but more joined.

The investors champion tip is from two days ago. Don't you think its a bit early to tell if its any good or not?
Posted at 27/10/2023 15:39 by red ninja
Investors Champion anknowledges the risks, but still likes them :-

"Why is it a Bonkers Bargain
We acknowledge this business has little real visibility and the departure of the former CEO has brought further uncertainty in a very fragile market, but the £85m valuation at a share price of 75p looks fantastic value for a business forecast to deliver pre-tax profits of £13.4m and earnings of 9p per share in the current year to December 2023 - PER 8x. Forecast free cash flow of £7.8m suggests a free cash flow yield of 9%, after a significant £4.3m of investment in capital expenditure to support of growth .

It’s resilience over the pandemic (and commitment to the dividend) should be commended, yet this is also not reflected in the share price.

The reinvigorated growth strategy is at an early stage. This includes developing new, higher value products (Structured Solutions); leveraging technology to embed the proposition more closely into the client’s day-to-day (Online trading, Alternative Banking); and capitalising on International growth through launch in both the Netherlands and Australia.

The Amsterdam office, which only opened in March 2020 and received its EMI licence in 2022, has been trading ahead of expectations and they await an Australian licence with the intention of opening in Sydney.

While AIM peer Alpha Group International (formerly AlphaFX) has developed a more extensive technology focused offering, and has been faster growing, it carries a rating nearly more than twice that of our Bonkers Bargain – ALPH: PER Dec 2023 28x. A high margin growth business delivering high returns on capital like Argentex justifies a much higher rating.

While additional costs will constrain earnings in the short term, these are in support of future growth.

Argentex is a simple, high return business, which avoids speculative FX trades and continues to focus on mainstream, low volatility currencies.

With growth having resumed the current £85m valuation (at 75 pence) remains firmly in Bonkers Bargain territory.

It remains a minnow in a market dominated by the large banking groups and a sizeable growth opportunity beckons.

Patient shareholders will also be rewarded with a now 4%+ dividend yield."

It goes without saying that not all Investor's Chamion tips succeed.
Posted at 10/7/2023 12:16 by thebeast1
I reckon it's due to the overall AIM market being depressed and investors market outlook currently. Doesn't look as an expensive stock and the in line is based on previous upgraded guidance. I reckon when overall investor outlook improves this will be a big winner. I am holding onto mine.

Your Recent History

Delayed Upgrade Clock